Chronic inflammation measured based on TNF-a, CRP, and IL-6, among others, is highly correlated with an increased risk of gastric cancer; those measurements can be practical in predicting gastric cancer development at very early stages [30]. The gene discussed is IL6; the disease is gastric cancer.